Pharmafile Logo
Pharmafocus logo
Advanced Search

merger

Showing 15 posts of 70 posts found.

Hospira image

Pfizer to buy Hospira for $17 billion

February 5, 2015
Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger

Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …

News

Sun Pharma and Ranbaxy merger gets US nod

February 2, 2015
Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent

The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …

News
GSK image

GSK-Novartis mega-deal signed-off by EC

January 29, 2015
Research and Development, Sales and Marketing Abbott, GSK, Mylan, Novartis, acquisition, etc, merger

The European Commission has approved a GSK-Novartis M&A deal, in which GSK will purchase Novartis’ vaccines unit and Novartis will …

News
Pfizer image

Pfizer buys OPKO growth hormone drug

December 16, 2014
Research and Development, Sales and Marketing Pfizer, ghd, growth, hGH-CTP, hormone, merger, opko

Pfizer will co-develop and commercialise OPKO’s growth hormone deficiency (GHD) drug hGH-CTP in a new agreement between the firms. The …

News
allergan image

Actavis buys Allergan for $66 billion

November 18, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger

The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …

News
Allergan image

Allergan eyeing Actavis buyout

November 13, 2014
Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Botox, Valeant, acquisition, buyout, merger

Allergan is attempting to block a recent Valeant hostile takeover bid by seeking the rumoured alternative merger deal with Actavis, …

News
Allergan image

Allergan and Valeant trade blows as shareholder meeting looms

November 6, 2014
Sales and Marketing Actavis, Allergan, Forest, Valeant, merger, warner

Allergan’s efforts to block a key supporter of Valeant’s hostile takeover bid from voting at next month’s special shareholder meeting …

News

AstraZeneca completes respiratory deal with Almirall

November 3, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory

AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …

News
james_bowling

Shire interim chief financial officer resigns

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger

Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of …

Appointment
Astrazeneca image

AstraZeneca shores up defences against Pfizer

August 22, 2014
Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger

AstraZeneca has been making a series of big deals over the past three months as it looks to close the …

News
Shire image

AbbVie agrees to buy Shire for £32bn

July 18, 2014
Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

News
Shire image

AbbVie makes fourth Shire offer

July 9, 2014
Sales and Marketing AbbVie, Abbott, Shire, buyout, merger

The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …

News
Shire image

AbbVie spells out Shire benefits

June 26, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger

AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …

News
AbbVie logo

AbbVie moves in on Shire with $46 billion bid

June 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

News
Pfizer image

Pfizer admits AstraZeneca defeat

May 27, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, Pfizer, Read, buyout, merger

Pfizer has acknowledged that it will not make an offer for AstraZeneca following the firms’ failure to agree a price …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025